EIF6 and metabolic dysfunction-associated steatotic liver disease: Deletion of one allele of eIF6 dramatically reduces lymphomagenesis [55] and the transition from NAFLD (non-alcoholic fatty liver disease) to hepatocellular carcinoma [56].